D.A. Davidson & Co. Axsome Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 8,160 shares of AXSM stock, worth $740,356. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,160

Previous 9,415 13.33%

Holding current value

$740,356

Previous $757,000 3.17%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.93 - $95.84 $99,057 - $120,279	-1,255 Reduced 13.33%	8,160 $733,000
Q2 2024 Jul 31, 2024	BUY	$65.72 - $80.5 $24,645 - $30,187	375 Added 4.15%	9,415 $757,000
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $124,902 - $175,752	1,800 Added 24.86%	9,040 $721,000
Q4 2023 Feb 09, 2024	SELL	$57.42 - $83.61 $10,909 - $15,885	-190 Reduced 2.56%	7,240 $576,000
Q3 2023 Nov 08, 2023	SELL	$69.25 - $82.21 $1,038 - $1,233	-15 Reduced 0.2%	7,430 $519,000
Q2 2023 Aug 10, 2023	SELL	$58.41 - $90.35 $4,380 - $6,776	-75 Reduced 1.0%	7,445 $534,000
Q1 2023 Apr 25, 2023	SELL	$58.39 - $75.0 $140,719 - $180,750	-2,410 Reduced 24.27%	7,520 $463,000
Q4 2022 Feb 03, 2023	SELL	$39.94 - $79.72 $33,949 - $67,762	-850 Reduced 7.88%	9,930 $765,000
Q3 2022 Nov 07, 2022	SELL	$36.06 - $69.85 $158,664 - $307,340	-4,400 Reduced 28.99%	10,780 $481,000
Q2 2022 Jul 28, 2022	BUY	$21.74 - $46.75 $3,695 - $7,947	170 Added 1.13%	15,180 $581,000
Q1 2022 May 12, 2022	BUY	$23.7 - $41.39 $15,997 - $27,938	675 Added 4.71%	15,010 $621,000
Q4 2021 Jan 31, 2022	SELL	$30.7 - $43.36 $61,093 - $86,286	-1,990 Reduced 12.19%	14,335 $542,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $139,170 - $477,137	6,990 Added 74.88%	16,325 $538,000
Q2 2021 Aug 10, 2021	BUY	$50.63 - $73.5 $17,973 - $26,092	355 Added 3.95%	9,335 $630,000
Q1 2021 May 07, 2021	BUY	$55.91 - $81.44 $99,240 - $144,556	1,775 Added 24.64%	8,980 $508,000
Q4 2020 Feb 10, 2021	BUY	$66.31 - $86.52 $13,593 - $17,736	205 Added 2.93%	7,205 $587,000
Q3 2020 Nov 02, 2020	BUY	$68.34 - $85.84 $212,195 - $266,533	3,105 Added 79.72%	7,000 $499,000
Q2 2020 Aug 10, 2020	BUY	$49.87 - $98.69 $194,243 - $384,397	3,895 New	3,895 $320,000
Q1 2020 May 05, 2020	SELL	$41.2 - $101.31 $146,260 - $359,650	-3,550 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $59,320 - $377,152	3,550 New	3,550 $367,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account